Specified Drug Use-Results Survey of Regnite
Phase of Trial: Phase IV
Latest Information Update: 30 Apr 2019
Price : $35 *
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 25 Apr 2019 Status changed from active, no longer recruiting to completed.
- 13 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Mar 2018 Planned End Date changed from 1 Jan 2019 to 1 Feb 2019.